FFCP PHASE2:Mm9::chr4:151699940..151699985,+
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p1@LOC100504863, p1@Rpl22 |
|---|---|
| Species: | Mouse (Mus musculus) |
| DPI dataset: | NA |
| TSS-like-by-RIKEN-classifier(Yes/No): | NA |
| DHS support(Yes/No): | NA |
| Description: | CAGE_peak_1_at_LOC100504863_5end, CAGE_peak_1_at_Rpl22_5end |
| Coexpression cluster: | MCL_coexpression_mm9:81 |
| Association with transcript: | 0bp_to_ENSMUST00000103191, ENSMUST00000139685_5end |
| EntrezGene: | 100504863,19934 |
| Link to Zenbu: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p1@LOC100504863p1@Rpl22 |
|---|
0
25
50
75
100
125
150
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| hematopoietic cell | 3.77e-15 | 32 |
| hematopoietic oligopotent progenitor cell | 3.77e-15 | 32 |
| hematopoietic stem cell | 3.77e-15 | 32 |
| hematopoietic multipotent progenitor cell | 3.77e-15 | 32 |
| motile cell | 4.57e-14 | 54 |
| connective tissue cell | 5.29e-13 | 46 |
| mesenchymal cell | 5.29e-13 | 46 |
| hematopoietic lineage restricted progenitor cell | 2.84e-12 | 25 |
| lymphoid lineage restricted progenitor cell | 1.04e-08 | 12 |
| lymphocyte | 1.21e-08 | 13 |
Showing 1 to 10 of 21 entries
| Ontology term | p-value | n |
|---|---|---|
| connective tissue | 5.29e-13 | 46 |
| hemolymphoid system | 1.10e-10 | 48 |
| immune system | 1.10e-10 | 48 |
| hematopoietic system | 2.38e-10 | 45 |
| blood island | 2.38e-10 | 45 |
Showing 1 to 5 of 5 entries
